Efthymia Kafantari

Medicine & Life Sciences

1. Whole Exome Sequencing 100%
2. Parkinson Disease, Familial, Type 1 66%
3. Trinucleotide Repeat Expansion 63%
4. Dystonia 61%
5. Dystonic Disorders 57%
6. Spinocerebellar Ataxias 56%
7. Ataxia 55%
8. Sweden 54%
9. Whole Genome Sequencing 53%
10. Homeobox Genes 48%
11. Zinc Fingers 47%
12. Tremor 45%
13. Genetic Testing 43%
14. Glycine 42%
15. Cognitive Dysfunction 40%
16. Phenotype 37%
17. Parkinson Disease 35%
18. Movement Disorders 35%
19. Dementia 35%
20. Genes 29%
21. Stroke 28%
22. Mutation 23%
23. Idiopathic basal ganglia calcification 1 19%
24. Gait 16%
25. Ataxia, Sensory, Autosomal Dominant 16%
26. Primary Dysautonomias 15%
27. Cerebral Small Vessel Diseases 15%
28. Genetic Databases 13%
29. Tandem Repeat Sequences 13%
30. Paraplegia 12%
31. Neuropathology 12%
32. Arterioles 11%
33. Cerebral Hemorrhage 11%
34. Genetic Association Studies 11%
35. Cerebrovascular Disorders 10%
36. Basal Ganglia 10%
37. Central Nervous System 10%
38. White Matter 9%
39. Intranuclear Inclusion Bodies 9%
40. Enteric Nervous System 9%
41. Patient Selection 9%
42. Virulence 9%
43. Vascular Endothelial Growth Factor A 9%
44. Autopsy 8%
45. alpha-Synuclein 8%
46. Saccades 8%
47. Communication 7%
48. Arteries 7%
49. Peripheral Nervous System 7%
50. Genotype 7%